(ABUS) Arbutus Biopharma complete technical analysis [charts+indicators] | Buy/Sell Arbutus Biopharma | (ABUS) share price targets
Complete technical analysis of Arbutus Biopharma (ABUS) by charts plus indicators, forecast predictions and share price targets for Arbutus Biopharma (ABUS)
Arbutus Biopharma trades in USA in Health Care sector.
Showing technical analysis as on 2024-03-22 View latest technical analysis
10 day averaged volume of Arbutus Biopharma is 676930
| Date | Daily Closing Price | Open | High | Low | Volume |
| 22 Fri Mar 2024 | 2.50 | 2.55 | 2.55 | 2.49 | 0.496 times |
| 21 Thu Mar 2024 | 2.55 | 2.57 | 2.60 | 2.53 | 0.886 times |
| 20 Wed Mar 2024 | 2.55 | 2.49 | 2.57 | 2.42 | 1.056 times |
| 19 Tue Mar 2024 | 2.50 | 2.52 | 2.58 | 2.49 | 0.587 times |
| 18 Mon Mar 2024 | 2.54 | 2.63 | 2.64 | 2.53 | 0.888 times |
| 15 Fri Mar 2024 | 2.62 | 2.59 | 2.64 | 2.56 | 2.192 times |
| 14 Thu Mar 2024 | 2.61 | 2.68 | 2.69 | 2.59 | 1.219 times |
| 13 Wed Mar 2024 | 2.70 | 2.70 | 2.74 | 2.67 | 1.022 times |
| 12 Tue Mar 2024 | 2.69 | 2.73 | 2.75 | 2.69 | 0.63 times |
| 11 Mon Mar 2024 | 2.72 | 2.71 | 2.79 | 2.71 | 0.826 times |
My analysis of stock is bearish for shortterm, but trade for tomorrow is selective. Take a sell trade only if stock stays below 2.6, but if it comes above 2.6, then a intra day buy could be more profitable.
If you take a sell trade below 2.6, then use 2.6 as stoploss and 2.4 as target. However if you take a buy trade in stock , then use 2.6 as stoploss and 2.69 as target.
Share price targets for Arbutus Biopharma (ABUS)
| Target Type | Value |
| Downside Target | 1.70 |
| Downside Target | 1.98 |
| Downside Target | 2.06 |
| Downside Target | 2.21 |
| Downside Target | 2.27 |
| Downside Target | 2.42 |
| Upside Target | 2.55 |
| Upside Target | 2.72 |
| Upside Target | 2.79 |
| Upside Target | 2.81 |
| Upside Target | 2.84 |
| Upside Target | 2.96 |
Intraday share price targets for Arbutus Biopharma (ABUS)
| Target Type | Value |
| Downside Intraday Target | 2.4 |
| Downside Intraday Target | 2.3 |
| Upside Intraday Target | 2.62 |
| Upside Intraday Target | 2.74 |
| Upside Intraday Target | 2.52 |
Weekly technical analysis of Arbutus Biopharma (ABUS)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 22 Fri Mar 2024 | 2.50 | 2.63 | 2.64 | 2.42 | 0.665 times |
| 15 Fri Mar 2024 | 2.62 | 2.71 | 2.79 | 2.56 | 1.433 times |
| 08 Fri Mar 2024 | 2.73 | 2.78 | 2.80 | 2.60 | 0.66 times |
| 01 Fri Mar 2024 | 2.79 | 2.91 | 2.96 | 2.72 | 1.103 times |
| 23 Fri Feb 2024 | 2.92 | 2.89 | 2.96 | 2.84 | 0.393 times |
Price has moved down this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Arbutus Biopharma (ABUS)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 22 Fri Mar 2024 | 2.50 | 2.78 | 2.81 | 2.42 | 0.34 times |
| 29 Thu Feb 2024 | 2.80 | 2.40 | 2.96 | 2.27 | 1.882 times |
| 31 Wed Jan 2024 | 2.37 | 2.49 | 2.63 | 2.21 | 1.159 times |
| 29 Fri Dec 2023 | 2.50 | 2.04 | 2.55 | 1.98 | 0.825 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Arbutus Biopharma (ABUS)
Price action analysis of Arbutus Biopharma ( (ABUS) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Arbutus Biopharma ( (ABUS) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Arbutus Biopharma ( (ABUS) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Arbutus Biopharma ( (ABUS) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Arbutus Biopharma stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Arbutus Biopharma in short term and the sell signal is strong.
Arbutus Biopharma Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Arbutus Biopharma in short term and SELL signal is strong!
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Arbutus Biopharma is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 2.61 and Arbutus Biopharma (ABUS) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Arbutus Biopharma (ABUS) stock. Volume based technical analysis of Arbutus Biopharma (ABUS) stock is negative.
Arbutus Biopharma Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Arbutus Biopharma ( (ABUS) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Arbutus Biopharma ( (ABUS) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Arbutus Biopharma ( (ABUS) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Arbutus Biopharma ( (ABUS) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Arbutus Biopharma stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Arbutus Biopharma in short term and the sell signal is strong.
Arbutus Biopharma Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be coming down
CCI has generated a SELL signal for Arbutus Biopharma in short term and SELL signal is strong!
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Arbutus Biopharma is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 2.61 and Arbutus Biopharma (ABUS) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Arbutus Biopharma (ABUS) stock. Volume based technical analysis of Arbutus Biopharma (ABUS) stock is negative.
Arbutus Biopharma Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.